"A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of BR3005 and Co-administration of BR3005-1 and BR3005-2 Under Fed Conditions in Healthy Adult Volunteers"

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 5, 2024

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG

BR3005

One tablet administered alone, Once a day

DRUG

BR3005-1

One tablet administered alone, Once a day

DRUG

BR3005-2

One tablet administered alone, Once a day

Trial Locations (1)

Clinical Research Center, H PLUS Yangji Hospital, Seoul